Unlike the association with colorectal cancer, there is almost no information about implication of AKAP9 in renal cancer, however, data of observational study presented in the Human Protein Atlas indicate that high expression of AKAP9 (median FPKM = 3.97 for survived and median FPKM = 3.27 for dead patients) is favorable in patients with renal carcinoma [71]. This evidence concerns the gene AKAP9 and renal carcinoma.